Menu
Dr Andreas Wallnoefer brings his extensive experience in growing business leadership positions, spending more than 25 years in the pharmaceutical and biotech industry, including 14 years in the F. Hoffmann-La Roche Roche R&D executive leadership team. Andreas has been Head of Cardiovascular & Metabolism R&D and member of the Roche / Genentech R&D Committee. He was part of several successful product developments and market introductions. Before the integration of Genentech, Andreas was Global Head of Clinical Research & Exploratory Development and led the R&D organization at multiple sites in Europe, US and Asia. He had a key role in the integration of the Roche and Genentech Development organizations and led subsequently Roche’s Early Development Department. After leaving Roche in 2015, Andreas has been become a successful as investor working with European Venture Capital companies and he has been involved in significant M&A exits. Andreas is and has been board member of several European biotech companies and is an expert in developing innovative companies.